Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks"

Movement Disorders : Official Journal of the Movement Disorder Society
Ida RisslingJ C Möller

Abstract

Genes encoding proteins involved in dopaminergic transmission are potential candidate genes for the induction of somnolence in Parkinson's disease (PD) because dopaminergic agents have been shown to be associated with sudden onset of sleep (SOS) in PD. We conducted an association study on dopamine D2, D3, and D4 receptor gene polymorphisms comparing 137 PD patients with SOS and 137 PD patients without SOS matched according to drug therapy, disease duration, sex, and age. Our results show a significant association between the dopamine D2 receptor gene polymorphism Taq IA and SOS in PD. No significant association between two other investigated polymorphisms and the phenomenon of "sleep attacks" in PD was observed.

References

Feb 1, 1979·Electroencephalography and Clinical Neurophysiology·G P MereuG L Gessa
Dec 1, 1992·Journal of Medical Genetics·M A CrocqJ C Schwartz
Oct 2, 1991·JAMA : the Journal of the American Medical Association·D E ComingsB W Kovacs
Sep 1, 1991·Human Genetics·M Le ConiatR Berger
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·S A FactorW J Weiner
Dec 1, 1993·Human Molecular Genetics·D K GrandyO Civelli
Mar 13, 1993·Lancet·S NankoS Kuwata
Oct 1, 1993·Genomics·A PetronisJ L Kennedy
Mar 1, 1993·Acta Neurologica Scandinavica·J J Askenasy
May 20, 1998·International Journal of Legal Medicine·L A Reyner, J A Horne
Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·K KarlsenK Jørgensen
Dec 3, 1999·American Journal of Medical Genetics·M I SeamanK K Kidd
Jan 14, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R L OliveriA Quattrone
Apr 25, 2000·Lancet·A H Schapira
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·L GrevleJ Aasly
Feb 2, 2002·JAMA : the Journal of the American Medical Association·Douglas E HobsonJonathan Fleming
Jun 22, 2002·BMJ : British Medical Journal·Carl Nikolaus HomannErwin Ott
Jul 12, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·J Carsten MöllerWolfgang H Oertel
May 2, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Eng-King TanYi Zhao
Jun 5, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian PausUllrich Wüllner

❮ Previous
Next ❯

Citations

Mar 15, 2005·Journal of Neurology·J C MöllerW H Oertel
Mar 10, 2009·Current Neurology and Neuroscience Reports·Renee Monderer, Michael Thorpy
Nov 19, 2011·International Journal of Clinical Practice·K KalinderiS Bostantjopoulou
Feb 18, 2011·CNS Drugs·Bettina KnieK Ray Chaudhuri
Feb 9, 2007·Pharmacogenomics·Maurits E L ArbouwHenk-Jan Guchelaar
Aug 22, 2014·Pharmacogenomics·Artur F Schumacher-SchuhMara H Hutz
Aug 12, 2009·Expert Opinion on Drug Metabolism & Toxicology·Sarah Vautier, Christine Fernandez
Mar 8, 2008·Expert Opinion on Drug Safety·Ubaldo Bonuccelli, Roberto Ceravolo
Apr 26, 2006·Expert Opinion on Pharmacotherapy·Lisa SkipperEng-King Tan
Feb 26, 2015·Neurodegenerative Disease Management·Mateusz KurzawskiMarek Droździk
Apr 23, 2016·Expert Review of Neurotherapeutics·Hee Jin Kim, Beomseok Jeon
Jan 31, 2015·Cephalalgia : an International Journal of Headache·Chunfang QiuMichelle A Williams
Nov 1, 2016·Movement Disorders Clinical Practice·Jean-Christophe Corvol, Werner Poewe
Dec 14, 2011·Annals of Neurology·Andrew ChanManuel Comabella
Sep 8, 2020·Pharmacogenomics·Sara Redenšek, Vita Dolžan
Nov 11, 2010·Sleep·Christian R BurgessJohn H Peever
Jun 10, 2011·Expert Review of Neurotherapeutics·Daniela Calandrella, Angelo Antonini
Jan 7, 2018·Neuromolecular Medicine·Cristina PolitiPaola Borgiani
Sep 1, 2014·Movement Disorders Clinical Practice·Eugene Y H Yeung, Andrea E Cavanna
Dec 12, 2018·Neural Regeneration Research·Cinzia Ciccacci, Paola Borgiani
Nov 11, 2020·International Journal of Environmental Research and Public Health·Yu JiangJiwen Liu
May 1, 2021·International Journal of Molecular Sciences·Luca MagistrelliFranca Marino
Jun 14, 2021·Parkinsonism & Related Disorders·Philippe A SallesHubert H Fernandez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.